These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8271953)

  • 21. Effects of intact fibrin and partially plasmin-degraded fibrin on kinetic properties of one-chain tissue-type plasminogen activator.
    Fischer BE; Will H
    Biochim Biophys Acta; 1990 Oct; 1041(1):48-54. PubMed ID: 2145980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A simple, sensitive spectrophotometric assay for extrinsic (tissue-type) plasminogen activator applicable to measurements in plasma.
    Verheijen JH; Mullaart E; Chang GT; Kluft C; Wijngaards G
    Thromb Haemost; 1982 Dec; 48(3):266-9. PubMed ID: 6891841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibrin-mediated plasminogen activation.
    Nieuwenhuizen W
    Ann N Y Acad Sci; 2001; 936():237-46. PubMed ID: 11460481
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of the cyanogen-bromide-2 fragment of fibrinogen on plasminogen activation by single-chain urokinase-type plasminogen activator.
    Kirchheimer JC; Resch I; Christ G; Wojta J; Binder BR
    Eur J Biochem; 1987 Jul; 166(2):393-7. PubMed ID: 3609016
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibrin-specific fibrinolysis.
    Collen D; Lijnen HR
    Ann N Y Acad Sci; 1992 Dec; 667():259-71. PubMed ID: 1285022
    [No Abstract]   [Full Text] [Related]  

  • 26. Influence of cyanogen-bromide-digested fibrinogen on the kinetics of plasminogen activation by urokinase.
    Lijnen HR; Van Hoef B; Collen D
    Eur J Biochem; 1984 Nov; 144(3):541-4. PubMed ID: 6489341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kinetic parameters for plasminogen activation by tissue type plasminogen activator.
    Machovich R
    Thromb Haemost; 1997 May; 77(5):1041-2. PubMed ID: 9184430
    [No Abstract]   [Full Text] [Related]  

  • 28. The influence of fibrin(ogen) fragments on the kinetic parameters of the tissue-type plasminogen-activator-mediated activation of different forms of plasminogen.
    Nieuwenhuizen W; Voskuilen M; Vermond A; Hoegee-de Nobel B; Traas DW
    Eur J Biochem; 1988 May; 174(1):163-9. PubMed ID: 3131143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trinitrobenzoylated poly(D-lysine) as a stimulator of interactions between plasminogen, plasmin, and tissue-type plasminogen activator.
    Petersen LC; Suenson E
    Biochim Biophys Acta; 1986 Sep; 883(2):313-25. PubMed ID: 2943320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reexamination of the extent of the activation of Lys78 plasminogen by tissue plasminogen activator in the presence of polymerized fibrin.
    Urano T; Takada Y; Ihara H; Takada A
    Haemostasis; 1996; 26(4):220-7. PubMed ID: 8872134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The mechanism of plasminogen activation and the variability of the fibrin effector during tissue-type plasminogen activator-mediated fibrinolysis.
    Thorsen S
    Ann N Y Acad Sci; 1992 Dec; 667():52-63. PubMed ID: 1309072
    [No Abstract]   [Full Text] [Related]  

  • 32. Vampire bat salivary plasminogen activator.
    Gardell SJ; Friedman PA
    Methods Enzymol; 1993; 223():233-49. PubMed ID: 8271956
    [No Abstract]   [Full Text] [Related]  

  • 33. Identification and characterization of novel tPA- and plasminogen-binding sites within fibrin(ogen) alpha C-domains.
    Tsurupa G; Medved L
    Biochemistry; 2001 Jan; 40(3):801-8. PubMed ID: 11170397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binding of synthetic B knobs to fibrinogen changes the character of fibrin and inhibits its ability to activate tissue plasminogen activator and its destruction by plasmin.
    Doolittle RF; Pandi L
    Biochemistry; 2006 Feb; 45(8):2657-67. PubMed ID: 16489759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Blood coagulation mechanism from the viewpoint of molecular biochemistry: Mechanism of fibrinolysis].
    Matsuda T
    Rinsho Byori; 1985 Sep; 33(9):982-8. PubMed ID: 2416968
    [No Abstract]   [Full Text] [Related]  

  • 36. Isolation and functional characterization of the heavy and light chains of human tissue-type plasminogen activator.
    Rijken DC; Groeneveld E
    J Biol Chem; 1986 Mar; 261(7):3098-102. PubMed ID: 3081501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of fibrin-like stimulators on the activation of plasminogen by tissue-type plasminogen activator (t-PA)--studies with active site mutagenized plasminogen and plasmin resistant t-PA.
    Lijnen HR; Van Hoef B; De Cock F; Collen D
    Thromb Haemost; 1990 Aug; 64(1):61-8. PubMed ID: 2148848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of oversulfated chondroitin-6-sulfate or oversulfated fucoidan in the activation of glutamic plasminogen by tissue plasminogen activator: role of lysine and cyanogen bromide-fibrinogen.
    Carranza YE; Anderson D; Doctor V
    Blood Coagul Fibrinolysis; 2008 Jan; 19(1):60-5. PubMed ID: 18180617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fibrin plate method with reagents purified by affinity chromatography and its use for determination of fibrinolytic and other proteolytic activity in saliva, bile and plasma.
    Norén I; Ramström G; Wallén P
    Haemostasis; 1975; 4(2):110-24. PubMed ID: 1332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A shift in balance between profibrinolytic and antifibrinolytic factors causes enhanced fibrinolysis in cirrhosis.
    Leebeek FW; Kluft C; Knot EA; de Maat MP; Wilson JH
    Gastroenterology; 1991 Nov; 101(5):1382-90. PubMed ID: 1718809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.